Posted 14 september 2016 in Okategoriserade
Bioaerosols: What will be the biological effects? On September 4-9 ISAB took PreciseInhale to Tours in central France for the European Aerosol Assembly’s (EAA’s) 2016 Conference. Interest was…
Read morePosted 14 september 2016 in Okategoriserade
On October 13, invited scientists travel to Stockholm for Experiences of Aerosol Exposure, a one-day seminar with ISAB founder Per Gerde, plus guest speakers from in vitro to…
Read morePosted 13 september 2016 in Okategoriserade
One of the world’s largest and most innovative chemical companies, Dow, has chosen ISAB’s PreciseInhale system for its work in Toxicology and Environmental Research. ISAB CEO Fredrik Sjövall:…
Read morePosted 13 september 2016 in Okategoriserade
One of the world’s largest and most innovative chemical companies, Dow, has chosen ISAB’s PreciseInhale system for its work in Toxicology and Environmental Research. ISAB CEO Fredrik Sjövall:…
Read morePosted 19 augusti 2016 in Okategoriserade
On September 26 ISAB founder and CSO Per Gerde will deliver an abstract on creating controllable aerosols for in vitro and in vivo tests to the 11th IPTC…
Read morePosted 19 augusti 2016 in Okategoriserade
On September 26 ISAB founder and CSO Per Gerde will deliver an abstract on creating controllable aerosols for in vitro and in vivo tests to the 11th IPTC…
Read morePosted 08 juli 2016 in Okategoriserade
In 1985 in vitro tests accounted for 1% of all R&D testing carried out by CROs and pharma companies. In 2013 it had risen to over 20%. The…
Read morePosted 08 juli 2016 in Okategoriserade
A new triplicate fraction collector lets ISAB’s in vitro simulation R&D tool DissolvIt run three experiments in parallel: a 200% increase in efficiency. ISAB’s fraction collector has long…
Read morePosted 08 juli 2016 in Okategoriserade
From 4-8 July Inhalation Sciences welcomed Graduate Research Assistant Ahmed Alobaida from Texas Tech University’s Health Sciences Center to its labs in Stockholm, Sweden. During his five-day visit…
Read morePosted 21 juni 2016 in Okategoriserade
XposeALI now simulates lung conditions more closely. New heat pads keep the system’s pumped perfusate at body temperature, 370 C. As a result XposeALI now provides PK (pharmacokinetic)…
Read more
